1 / 15

Global Trends Impacting Statistics & Programming Roles in Pharma Industry

Explore the evolving global trends in statistics and programming, their impact on roles in the pharma industry, and the necessary skills to navigate this changing landscape. Key topics include healthcare pressures, regulatory changes, outsourcing strategies, and technological advancements.

civory
Download Presentation

Global Trends Impacting Statistics & Programming Roles in Pharma Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The company of specialists. What are the global trends that we are seeing in Statistics and Programming? How does this impact our roles?

  2. What are the global trends that we are seeing in Statistics and Programming? How does this impact our roles? Gail Kniveton I3 Pharma Resourcing +44 1895 451 801 gail@i3pr.com

  3. Considerations • Approach • Pressures from: • Health care • Drug pricing • Drug development • Changes in the regulatory environment • Outsourcing and offshoring strategies • Changing technologies and e-patient records • Trial designs • How does this impact your roles?

  4. Approach • Qualitative review based on opinion • Opinion leaders • For discussion and your opinions

  5. Pressures on Health care, drug pricing and generics • Governments globally looking for cost effective healthcare • Drug pricing • More health economics and outcomes research • Patient recorded outcomes • E-patient records • How far is this away? • Use of generics companies • Lower cost drug production • Patent law differences • Medical ethics • Observational trials, metadata and epidemiology

  6. Pressures on Health care, drug pricing and generics • Impact on roles: • Looking for more cost effective research • More guidance via regulatory authorities • Use of new technologies/ processes • Use of lower cost resource • Outcomes based research • Epidemiology

  7. Changes in the Regulatory Environment • Regulatory authorities • Offer guidelines and regulations around design, management and assessment of clinical trials • Patient safety • Do they understand the statistical design and significance of results? (ref 1) • Data Standardisation to facilitate review and reporting by regulatory authority e.g. • CDISC, CDASH, ADAM, SDTM • Alligning/ interpreting your company standards • CFR 21 part 11 for SAS applications (ref 2)

  8. Changes in the Regulatory Environment • FDAAA 2007 (US ref 3) • Registration of all trials • All results to be published within 1 year • Visibility of competitors drugs, endpoints, analysis and results • Impact on roles • Must keep on top of regulatory changes • Engage experts • Internal • External • Consultancies • Training/ best practise forums • internal • via associations e.g. Phuse

  9. Outsourcing and offshoring strategies • Outsourcing historically was by project • Big move to multi-project and longer term partnership deals • Impact on roles • Improve communications skills • Project management skills • Working in or managing remote teams • Multi-timezone/ multi-cultural working • Lack of “junior” or “training” roles (US and Europe)

  10. Changing technologies and e-patient records • Technology version updates • Will SAS ever be challenged? • R, SPLUS, Winbugs, Winnonlin • Merging data from different sources for analysis • What impact will direct access to patients records have in future? • Impact on roles • Constantly learning new systems, languages and formats • Technology/ software supplier training • Train the trainers • Version controls

  11. Trial designs • Regulatory updates • Able to view competitors designs (e.g. FDAAA) • Adaptive trials • Health economics/ outcomes • Impact on roles • Being informed about these updates • Understanding the methodologies • Applying this to your company standards and roles

  12. Behavioural Competencies (stats programmers) • Flexible • Attention to detail • Ability to work under pressure • Starter/ Finisher • Organised • Logical thinking • Problem solving • Ability to simplify complex ideas to communicate to non-technical users

  13. So, what are the important skills to have and how do you get them? • Technical • SAS updates • Company training • , Phuse • Regulatory • Review and interpret guidelines/ regulations • Use specialists (contractors or CRO) • Phuse, TOPRA

  14. So, what are the important skills to have and how do you get them? Part 2 • Soft skills (behaviours) • Inhouse training • Face-to-face • Internet webinars • Phuse

  15. References • Ref 1 BMJ  2008;336:250 (2 February), Open letter, Sara Hughes • Ref 2 Implementing CFR 21 part 11 D.J. Garbutt • Ref 3 http://www.fda.gov/oc/initiatives/advance/fdaaa.html • http://www.cdisc.org/ • http://www.21cfrpart11.com/

More Related